Phyllis Windsor

Public Member

Phyllis Windsor

Dr Phyllis Windsor MBE qualified in medicine from St. Mary’s Hospital Medical School in London in 1977, spending four decades working in the NHS, with 28 years as a Consultant Clinical Oncologist in Dundee.

She has been active in clinical research throughout her career, with 49 peer-reviewed publications.

She chaired the Tayside Local Research Ethics Committee for six years and also chaired the Tayside Urology Cancer Network.

Phyllis was awarded an MBE in 2004 for services to radiotherapy.

She participated in Health Improvement Scotland’s Quality Performance Indicators for bladder cancer, prostate cancer, and patient experience and was the oncology representative on the Scottish Medicines Consortium (the equivalent of NICE).

Additionally, she acted as club doctor in Scottish men’s professional football from 1992-2017 and also worked for various National women’s age squads on trips abroad. She gained MSc degrees in Sport and Exercise Medicine, Applied Sport and Exercise Psychology, and a psychology conversion course.

In 2006/7 she was diagnosed with a locally advanced pituitary tumour (treated by surgery and radiotherapy), inflammatory arthritis, and a congenital bicuspid aortic valve, for which she had open heart surgery for an aortic valve replacement in 2008, having been on warfarin since then but requiring cardiac ablation for postsurgical atrial fibrillation in 2011. Three days after back surgery in 2019 she had a major stroke, affecting her left hand and speech, with dyscalculia and initial post-stroke emotionalism. She has significant disability, with loss of balance from bilateral vestibular failure due to tobramycin toxicity in 2012 and being registered partially sighted due to bouncing vision and reduced visual fields following her pituitary tumour treatment and stroke.

However, after a two-year gap from her studies, she successfully completed a PhD in cognitive psychology in 2023. She now wishes to use her experience in order to contribute to research into heart disease and stroke.